4'-Fluoro-1',2'-dihydrospiro[cyclobutane-1,3'-indole]

Catalog No. :
ACPENJ764
CAS No. :
1240527-22-3
Molecular Formula :
C11H12FN
Molecular Weight :
177.22

IUPAC Name:4'-fluorospiro[cyclobutane-1,3'-indoline]

4'-Fluoro-1',2'-dihydrospiro[cyclobutane-1,3'-indole] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$310.00Login to see priceInquiryInquiry
250mg97%$495.00Login to see priceInquiryInquiry
500mg97%$823.00Login to see priceInquiryInquiry
1g97%$1233.00Login to see priceInquiryInquiry
5g97%$3699.00Login to see priceInquiryInquiry
10g97%$6164.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4'-Fluoro-1',2'-dihydrospiro[cyclobutane-1,3'-indole]
IUPAC Name4'-fluorospiro[cyclobutane-1,3'-indoline]
MDL No.MFCD16547558
Molecular FormulaC11H12FN
Molecular Weight177.22
SMILESFC1=CC=CC(NC2)=C1C32CCC3
InChI KeyUGTOPGDNTREJMX-UHFFFAOYSA-N
Synonym4-fluorospiro[1,2-dihydroindole-3,1'-cyclobutane] | MFCD16547558 | D79203 | CS-0304775 | EN300-62538 | 4'-fluoro-1',2'-dihydrospiro[cyclobutane-1,3'-indole] | 4 inverted exclamation mark -Fluorospiro[cyclobutane-1,3 inverted exclamation mark -indoline] |
CAS No.1240527-22-3
PubChem CID47002997

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACPENJ764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPENJ764 route product structure diagram
    ACPENJ7641240527-22-3
Inquiry

2. ACPENJ764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPENJ764 route product structure diagram
    ACPENJ7641240527-22-3
Inquiry

Comments (0)